Dependency of Tamoxifen Sensitive and Resistant ER+ Breast Cancer Cells on Semaphorin 3C (SEMA3C) for Growth

被引:3
|
作者
Bhasin, Satyam [1 ,2 ]
Dusek, Christopher [1 ,2 ]
Peacock, James W. [1 ,2 ]
Cherkasov, Artem [1 ,2 ]
Wang, Yuzhuo [1 ,2 ]
Gleave, Martin [1 ,2 ]
Ong, Christopher J. [1 ,2 ]
机构
[1] Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada
[2] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada
关键词
ER+ breast cancer; Semaphorin; 3C; plexin-B1; siRNA knockdown; Akt-MAPK signaling; apoptosis; B1SP; tamoxifen-resistance; EXPRESSION; MECHANISMS; IMPACT;
D O I
10.3390/cells12131715
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Estrogen receptor positive (ER+) breast cancer (BCa) accounts for the highest proportion of breast cancer-related deaths. While endocrine therapy is highly effective for this subpopulation, endocrine resistance remains a major challenge and the identification of novel targets is urgently needed. Previously, we have shown that Semaphorin 3C (SEMA3C) is an autocrine growth factor that drives the growth and treatment resistance of various cancers, but its role in breast cancer progression and endocrine resistance is poorly understood. Here, we report that SEMA3C plays a role in maintaining the growth of ER+ BCa cells and is a novel, tractable therapeutic target for the treatment of ER+ BCa patients. Analyses of publicly available clinical datasets indicate that ER+ BCa patients express significantly higher levels of SEMA3C mRNA than other subtypes. Furthermore, SEMA3C mRNA expression was positively correlated with ESR1 mRNA expression. ER+ BCa cell lines (MCF7 and T47D) expressed higher levels of SEMA3C mRNA and protein than a normal mammary epithelial MCF10A cell line. ER siRNA knockdown was suppressed, while dose-dependent beta-estradiol treatment induced SEMA3C expression in both MCF7 and T47D cells, suggesting that SEMA3C is an ER-regulated gene. The stimulation of ER+ BCa cells with recombinant SEMA3C activated MAPK and AKT signaling in a dose-dependent manner. Conversely, SEMA3C silencing inhibited Estrogen Receptor (ER) expression, MAPK and AKT signaling pathways while simultaneously inducing apoptosis, as monitored by flow cytometry and Western blot analyses. SEMA3C silencing significantly inhibited the growth of ER+ BCa cells, implicating a growth dependency of ER+ BCa cells on SEMA3C. Moreover, the analysis of tamoxifen resistant (TamR) cell models (TamC3 and TamR3) showed that SEMA3C levels remain high despite treatment with tamoxifen. Tamoxifen-resistant cells remained dependent on SEMA3C for growth and survival. Treatment with B1SP Fc fusion protein, a SEMA3C pathway inhibitor, attenuated SEMA3C-induced signaling and growth across a panel of tamoxifen sensitive and resistant ER+ breast cancer cells. Furthermore, SEMA3C silencing and B1SP treatment were associated with decreased EGFR signaling in TamR cells. Here, our study implicates SEMA3C in a functional role in ER+ breast cancer signaling and growth that suggests ER+ BCa patients may benefit from SEMA3C-targeted therapy.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
    Moon, Seo Yun
    Lee, Heejin
    Kim, Seoree
    Hong, Ji Hyung
    Chun, Sang Hoon
    Lee, Hee Yeon
    Kang, Keunsoo
    Kim, Ho Shik
    Won, Hye Sung
    Ko, Yoon Ho
    BMC CANCER, 2021, 21 (01)
  • [42] The effect of silencing the insulin-like growth factor receptor on tamoxifen sensitive and tamoxifen resistant breast cancer cells.
    McVittie, CJ
    Khalaf, S
    Ogunkolade, BW
    Bustin, SA
    Jenkins, PJ
    Carpenter, R
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S195 - S195
  • [43] Estrogen Suppresses MLK3-Mediated Apoptosis Sensitivity in ER+ Breast Cancer Cells
    Rangasamy, Velusamy
    Mishra, Rajakishore
    Mehrotra, Suneet
    Sondarva, Gautam
    Ray, Rajarshi S.
    Rao, Arundhati
    Chatterjee, Malay
    Rana, Basabi
    Rana, Ajay
    CANCER RESEARCH, 2010, 70 (04) : 1731 - 1740
  • [44] Semaphorin 3C drives invasiveness in prostate cells through epithelial-to-mesenchymal transition and stemness
    Tam, Kevin J.
    Hui, Daniel H.
    Lee, Wilson C.
    Dong, Mingshu
    Tombe, Tabitha
    Jiao, Ivy Z.
    Khosravi, Shahram
    Takeuchi, Ario
    Peacock, James W.
    Ivanova, Larissa
    Moskalev, Igor
    Gleave, Martin E.
    Buttyan, Ralph
    Cox, Michael E.
    Ong, Christopher J.
    CANCER RESEARCH, 2018, 78 (13)
  • [45] TOX3 is expressed in mammary ER+ epithelial cells and regulates ER target genes in luminal breast cancer
    Seksenyan, Akop
    Kadavallore, Asha
    Walts, Ann E.
    de la Torre, Brian
    Berel, Dror
    Strom, Samuel P.
    Aliahmad, Parinaz
    Funari, Vincent A.
    Kaye, Jonathan
    BMC CANCER, 2015, 15
  • [46] TOX3 is expressed in mammary ER+ epithelial cells and regulates ER target genes in luminal breast cancer
    Akop Seksenyan
    Asha Kadavallore
    Ann E Walts
    Brian de la Torre
    Dror Berel
    Samuel P Strom
    Parinaz Aliahmad
    Vincent A Funari
    Jonathan Kaye
    BMC Cancer, 15
  • [47] Effects of Notch signalling on the expression of SEMA3C, HMGA2, CXCL14, CXCR7, and CCL20 in breast cancer
    Kucukkose, Cansu
    Yalcin Ozuysal, Ozden
    TURKISH JOURNAL OF BIOLOGY, 2019, 43 (01) : 70 - 76
  • [48] Reprogramming of TFAP2C Regulation Promotes Tamoxifen Resistance in ER plus Breast Cancer Cells
    Charles, Paul
    Whitman, Austin A.
    Haase, Santiago
    Brunk, Elizabeth
    Spanheimer, Philip
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S57 - S57
  • [49] FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity
    Fiorillo, Marco
    Ricci, Elena
    Fava, Mariarosa
    Longobucco, Camilla
    Sotgia, Federica
    Rizza, Pietro
    Lanzino, Marilena
    Bonofiglio, Daniela
    Conforti, Francesca Luisa
    Catalano, Stefania
    Barone, Ines
    Morelli, Catia
    Aquila, Saveria
    Lisanti, Michael P.
    Sisci, Diego
    CELLS, 2023, 12 (24)
  • [50] Semaphorin 3C Released from a Biocompatible Hydrogel Guides and Promotes Axonal Growth of Rodent and Human Dopaminergic Neurons
    Carballo-Molina, Oscar A.
    Sanchez-Navarro, Andrea
    Lopez-Ornelas, Adolfo
    Lara-Rodarte, Rolando
    Salazar, Patricia
    Campos-Romo, Aurelio
    Ramos-Mejia, Veronica
    Velasco, Ivan
    TISSUE ENGINEERING PART A, 2016, 22 (11-12) : 850 - 861